Entourage Health Corp. announced today it will file its second quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, August 29, 2022.

Entourage Health Corp. is pleased to announce it has entered into an exclusive licensing, manufacturing and distribution agreement with Irwin Naturals Inc., a renowned nutraceuticals and herbal supplement formulator of popular branded wellness products sold across North America.

Entourage Health Corp. confirmed today it has satisfied certain conditions in connection with the recent amendments to its existing senior secured credit facility entered into on March 29, 2019 between the Company and Bank of Montreal, and its existing second secured credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, entered into on September 30, 2020.

Entourage Health Corp. is pleased to announce the expansion of its Starseed Medicinal offerings and services as it partners with HelloMD, a leading online cannabis telehealth Company, to expand patient access to experienced and knowledgeable healthcare practitioners across Canada.

Entourage Health Corp. is pleased to announce it has amended its existing senior secured credit facility entered into on March 29, 2019 between the Company and Bank of Montreal, and its existing second secured credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, entered into on September 30, 2020.

Entourage Health Corp. announced today it has amended and upsized its existing credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, adding an additional $8.9 million in non-dilutive funding availability.

Entourage Health Corp. is pleased to provide an update on the previously announced proposed amendments to the trust indenture dated as of September 25, 2019 between TSX Trust Company and the Company governing the Company’s 8.5% unsecured convertible debentures due September 25, 2022.

Entourage Health Corp. is pleased to announce that holders of the Company’s 8.5% unsecured convertible debentures due September 25, 2022, overwhelmingly approved the previously announced proposed amendments to the trust indenture dated as of September 25, 2019 between TSX Trust Company and the Company governing the Debentures.

Entourage Health Corp. is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general and special meeting of shareholders (“AGM”) held virtually in Toronto, Ontario on June 10, 2022.

Entourage Health Corp. confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019.

Entourage Health Corp. announced today its financial results for the three months ended March 31, 2022.

Entourage Health Corp. and The Boston Beer Company, Inc. are pleased to announce the Canadian debut of ‘TeaPot’, a new line of cannabis-infused iced tea beverages.

Entourage Health Corp. announced today that it is scheduled to file its first quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, May 30, 2022.

Entourage Health Corp. is pleased to announce that it has entered into voting support agreements with certain holders of the Company’s 8.5% unsecured convertible debentures due September 25, 2022…

Entourage Health Corp. announced today that George Scorsis, CEO and Executive Chair, and Vaani Maharaj, Chief Financial Officer, are scheduled to present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on Thursday, May 11th at 1 p.m. ET.

Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.

Entourage Health Corp. announced today that the Ontario Securities Commission (the “OSC”) has issued a Cease Trade Order (the “CTO”) as a result of the Company not filing its financial statements for the year ended December 31, 2021 and the related management’s discussion and analysis and CEO and CFO certifications (collectively, the “Annual Filings”) by May 2, 2022, being the date that such filings were due under applicable Canadian securities laws.

Entourage Health Corp. announced today it has entered into an agreement with Fire & Flower Holdings Corp., a leading cannabis consumer retail and technology platform and its wholly owned delivery and logistics subsidiary, Pineapple Express Delivery Inc. to offer same-day and next-day delivery services to the Company’s Starseed Medicinal patients.

Entourage Health Corp. announced today it will defer its fourth quarter and full-year 2021 press release and conference call previously scheduled for May 3, 2022, to coincide with its projected first quarter 2022 financial results, expected on or before May 31, 2022.

Entourage Health Corp. is pleased to announce it has amended and upsized its existing credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, adding an additional $15 million in funding availability.